Search | IOVS | ARVO Journals

Showing 1 – 20 of 146

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2025

Short- and Long-Term Retest Variability of Blood Flow in Healthy Subjects Using Laser Speckle Flowgraphy

Edward Fort Linton; Michael Jones; Julie Nellis; Riley Fillister; Randy H Kardon

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):4238.

ARVO Annual Meeting Abstract June 2025

PDE6A gene augmentation therapy maintains rescue for up to 60 months in a dog model

Simon M Petersen-Jones; Billie Beckwith-Cohen; Laurence M Occelli; Paige A Winkler; Kelian Sun; Lena Hennis; Pavel Kielkowski; Stylianos Michalakis

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):2495.

ARVO Annual Meeting Abstract June 2025

A canine model of Stargardt Disease 1 develops early cone dysfunction recapitulating the human phenotype

Alexandra J Azarkevich; Paige A Winkler; Alexis M Daggy; Laura Michele Ford; Suvi Mäkeläinen; Bjorn Ekesten; Janet R Sparrow; Tomas F Bergström; Simon M Petersen-Jones

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):2461.

ARVO Annual Meeting Abstract June 2025

Impact of Port Delivery System with ranibizumab (PDS) treatment in study eyes vs anti-VEGF injections in fellow eyes on efficacy and safety outcomes in patients with bilateral diabetic macular edema (DME) in the Pagoda trial

Robert Samuel Wirthlin; David Eichenbaum; Jordan M Graff; Patricia Udaondo; Yi-Ting Hsieh; Jason Hsu; Steven Blotner; Shamika Gune; Melissa Kaye Jones; Anjana Santhanakrishnan; Andrea Schimpl; DOMINIC HEINRICH

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):2378.

ARVO Annual Meeting Abstract June 2025

Gene augmentation therapy imparts partial visual recovery in a large animal model of GUCY2D Leber congenital amaurosis (LCA1)

Billie Beckwith-Cohen; Paige A Winkler; Alexandra J Azarkevich; Kelian Sun; Geneive M. Carrion; Mariza Bortolini; Fabiano Montiani Ferreira; Shannon Elizabeth Boye; Sanford L. Boye; Simon M Petersen-Jones

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):2699.

ARVO Annual Meeting Abstract June 2024

Utility of STZ-diabetic Townes humanized mice to study diverse phenotypes in diabetic retinopathy

Malita Jones; Ronny Amamoo; Samantha Jones; Folami Lamoke Powell; Menaka Thounaojam; Ravirajsinh Jadeja; Pamela M Martin

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):318.

ARVO Annual Meeting Abstract June 2024

Cone contributions to the ERG of the RPE65 -/- dog

Geneive M Carrion; Paige A Winkler; Kelian Sun; Laurence Occelli; Simon M Petersen-Jones

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):4740.

ARVO Annual Meeting Abstract June 2024

Type I interferon signaling shapes B cell phenotype and pathogenicity in the nonobese diabetic (NOD) mouse model of Sjögren’s disease

Merri-Grace Jones; Ivy Debreceni; Scott Lieberman

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5053.

ARVO Annual Meeting Abstract June 2024

AAV2 gene therapy rescues rod photoreceptor functional recovery in the RDH5 -mutant cat

Laura Ford; Laurence Occelli; Kelian Sun; Mary Enfield; William Hauswirth; Simon M Petersen-Jones

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6080.

Retina June 2023

Cat LCA- CRX Model, Homozygous for an Antimorphic Mutation Has a Unique Phenotype

PDF

Laurence M. Occelli; Nicholas M. Tran; Shiming Chen; Simon M. Petersen-Jones
TAGS: cats, eye, homozygote, mutation, phenotype, photoreceptors, retina, spectral domain-optical coherence tomography, transcription factor, tissue degeneration
Trans. Vis. Sci. Tech.. 2023; 12(6):15. https://doi.org/10.1167/tvst.12.6.15

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2023

Maturation of synaptic ribbons and synaptogenesis occur after CaBP4 gene augmentation therapy

Billie Beckwith-Cohen; Paige A Winkler; Kelian Sun; Laurence M Occelli; Luis Felipe Marinho; Fabiano Montiani-Ferreira; William W Hauswirth; Simon M Petersen-Jones

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1915.

ARVO Annual Meeting Abstract June 2023

Human pluripotent stem cell-derived retinal ganglion cells and their potential to study axonal degeneration in glaucomatous optic neuropathy

Pooja Teotia; Carmen Sandoval; Melissa Kaye Jones; Tao Sun; Tiffany Heaster; Fatima Abbas; Michelle Chen; Marion Jeanne

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1560.

ARVO Annual Meeting Abstract June 2023

Exploring the uptake and efficacy of topical Ranibizumab

Paul Roberts; James Andrews; Chloe Thomas; Marie-Christine Jones; Lisa Hill

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):2208.

ARVO Annual Meeting Abstract June 2023

Transcriptomic comparison of in vitro and in vivo models for retinal dystrophy

Melissa Kaye Jones; Luz Orozco; Han Qin; Tom Truong; Justin Elstrott; Zora Modrusan; Shawnta Chaney; Marion Jeanne

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3198.

Vision Sciences Society Annual Meeting Abstract December 2022

OPA responds to visual information about walking, not crawling

Christopher M Jones; Joshua Byland; Daniel D Dilks

Journal of Vision. 2022; 22(14):4072. https://doi.org/10.1167/jov.22.14.4072

ARVO Annual Meeting Abstract June 2022

HBI-002 treatment improves retinal ischemia-reperfusion injury in mice

Ravirajsinh Jadeja; Edward Gomperts; Howard Levy; Leo Otterbein; Mark Young; Malita Jones; Menaka Thounaojam; Manuela Bartoli; Andrew Gomperts; Pamela M Martin

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2983 – F0224.

ARVO Annual Meeting Abstract June 2022

Regulation of retinal endothelial cell barrier function by the hydroxycarboxylic acid receptor 2 (HCAR2)/GPR109A

Pamela M Martin; Ammar Abdelrahman; Folami Lamoke Powell; Menaka Thounaojam; Malita Jones; Manuela Bartoli; Ravirajsinh Jadeja

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3619 – A0074.

ARVO Annual Meeting Abstract June 2022

Temporal and isoform-specific expression analysis of the multiuse CTBP2/RIBEYE locus in the developing chicken and human retina.

Ray Enke; Devansh Agarwal; Elizabeth Gage; Calvin Chenault; Kameron Washington-Brown; Sarah Szvetecz; Nusrat Jahan; Melissa Kaye Jones; Donald J Zack; Karl J Wahlin

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):496 – A0073.

ARVO Annual Meeting Abstract June 2021

Ocular Characteristic in a Cohort of Neuronal Ceroid Lipofuscinoses/ Batten Disease Patients

Elisa Eleanor Cornish; Dhimas Hari Sakti; Clare Fraser; Trent Sandercoe; Michael M Jones; Neil A Rowe; Robyn V Jamieson; John R Grigg

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):618.

ARVO Annual Meeting Abstract June 2021

A disease-modifying therapy for retinal degenerations by drug repurposing

Henri Olavi Leinonen; Jianye Zhang; Fangyuan Gao; Elliot H Choi; Elliott E Einstein; David E Einstein; Laurence Mireille Occelli; Luis Felipe Marinho; Alexander V Kolesnikov; Vladimir Kefalov; Dorota Skowronska-Krawczyk; Seth Blackshaw; Simon M Petersen-Jones; Krzysztof Palczewski

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3157.

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

Short- and Long-Term Retest Variability of Blood Flow in Healthy Subjects Using Laser Speckle Flowgraphy

PDE6A gene augmentation therapy maintains rescue for up to 60 months in a dog model

A canine model of Stargardt Disease 1 develops early cone dysfunction recapitulating the human phenotype

Impact of Port Delivery System with ranibizumab (PDS) treatment in study eyes vs anti-VEGF injections in fellow eyes on efficacy and safety outcomes in patients with bilateral diabetic macular edema (DME) in the Pagoda trial

Gene augmentation therapy imparts partial visual recovery in a large animal model of GUCY2D Leber congenital amaurosis (LCA1)

Utility of STZ-diabetic Townes humanized mice to study diverse phenotypes in diabetic retinopathy

Cone contributions to the ERG of the RPE65 -/- dog

Type I interferon signaling shapes B cell phenotype and pathogenicity in the nonobese diabetic (NOD) mouse model of Sjögren’s disease

AAV2 gene therapy rescues rod photoreceptor functional recovery in the RDH5 -mutant cat

Cat LCA- CRX Model, Homozygous for an Antimorphic Mutation Has a Unique Phenotype

Maturation of synaptic ribbons and synaptogenesis occur after CaBP4 gene augmentation therapy

Human pluripotent stem cell-derived retinal ganglion cells and their potential to study axonal degeneration in glaucomatous optic neuropathy

Exploring the uptake and efficacy of topical Ranibizumab

Transcriptomic comparison of in vitro and in vivo models for retinal dystrophy

OPA responds to visual information about walking, not crawling

HBI-002 treatment improves retinal ischemia-reperfusion injury in mice

Regulation of retinal endothelial cell barrier function by the hydroxycarboxylic acid receptor 2 (HCAR2)/GPR109A

Temporal and isoform-specific expression analysis of the multiuse CTBP2/RIBEYE locus in the developing chicken and human retina.

Ocular Characteristic in a Cohort of Neuronal Ceroid Lipofuscinoses/ Batten Disease Patients

A disease-modifying therapy for retinal degenerations by drug repurposing

To View More...

You must be signed into an individual account to use this feature.